Moolec Science SA (MLEC)
1.170
-0.03
(-2.11%)
USD |
NASDAQ |
May 31, 16:00
1.18
+0.01
(+0.85%)
After-Hours: 20:00
Moolec Science Cash from Operations (Quarterly): -3.904M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.904M |
| September 30, 2023 | -1.744M |
| June 30, 2023 | -2.665M |
| Date | Value |
|---|---|
| March 31, 2023 | -4.264M |
| December 31, 2022 | -0.5927M |
| September 30, 2022 | 0.0096M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.264M
Minimum
Mar 2023
0.0096M
Maximum
Sep 2022
-2.193M
Average
-2.204M
Median
Cash from Operations (Quarterly) Benchmarks
| Alvotech | -75.40M |
| Procaps Group SA | 47.39M |
| Sunshine Biopharma Inc | -3.185M |
| Bio-Path Holdings Inc | -1.038M |
| Palisade Bio Inc | -3.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.1281M |
| Cash from Financing (Quarterly) | 4.82M |
| Free Cash Flow | -12.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1031 |
| Free Cash Flow to Equity (Quarterly) | -9.350M |
| Free Cash Flow to Firm (Quarterly) | -3.697M |
| Free Cash Flow Yield | -28.90% |